ALOPECIAgen targets the androgen receptor and three other polymorphisms involved in the development of androgenetic alopecia. The ALOPECIAgen profile analyzes and allows to distinguish between three different risk groups before the occurrence of any symptoms.
Depending on the risk and the gender, a treatment with minoxidil and/or finasteride may be recommended. Other nutrigenetic and lifestyle recommendations given in the profile may contribute to the prevention of androgenetic alopecia.
This test is carried out on a sub-contracted basis by an accredited laboratory.